Outcome in Patients Treated with Intraarterial Thrombectomy - OptiMAL Blood Pressure Control (OPTIMAL-BP)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 306 participants.

Also called NCT04205305

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 306 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04205305
Other papers using this trial's data
  • Acute Kidney Injury After Intensive Blood Pressure Lowering Following Successful Endovascular Thrombectomy Stroke, 2026-09 DOI, PubMed 42495732
  • Association Between Intravenous Antihypertensives and Functional Outcome After Successful Endovascular Thrombectomy Stroke, 2025-09 DOI, PubMed 40605757
  • Blood pressure management based on infarct volume after successful endovascular thrombectomy European stroke journal, 2025-12 DOI, PubMed 40317165, PMC12049365 Not in the PMC Open Access subset.
  • Effects of blood pressure lowering in patients treated with intravenous thrombolysis before endovascular thrombectomy International journal of stroke : official journal of the International Stroke Society, 2025-07 DOI, PubMed 39819210
  • Intensive Versus Conventional Blood Pressure Lowering After Successful Endovascular Thrombectomy: OPTIMAL-BP 1-Year Outcomes Stroke, 2026-08 DOI, PubMed 42212393
  • Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial JAMA, 2023-09-05 DOI, PubMed 37668619, PMC10481233 Not in the PMC Open Access subset.
  • Poorer Outcomes With Blood Pressure Lowering in Severe White Matter Disease After Thrombectomy Stroke, 2026-05 DOI, PubMed 41744094

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04205305. Randomized; single masking; primary purpose treatment. Start 2020-06-18 (actual); primary completion 2023-07-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Outcome in Patients Treated with Intraarterial Thrombectomy - OptiMAL Blood Pressure Control (OPTIMAL-BP)
Intervention (Drug)
conventional blood pressure control (labetalol, nicardipine)
Intervention (Drug)
intensive blood pressure control (labetalol, nicardipine)
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct04205305
Content hash
0da1c05b7a87f83c80d8e52daac85bdb14197e725527018d37c95019fbf82460